Short answer · Medically reviewed summary · Last updated: 2023-07-13
C3 Glomerulopathy (C3G) is a rare kidney disorder characterized by abnormal deposits of a protein called C3 in the glomeruli, which are the tiny blood vessels in the kidneys responsible for filtering waste and excess fluid from the blood. C3G is a type of glomerulonephritis, a group of diseases that cause inflammation and damage to the glomeruli. The prevalence of C3G is not well-established due to its rarity and the challenges in diagnosing the condition.
What is the prevalence of C3 Glomerulopathy C3G?
Prevalence of C3 Glomerulopathy C3G: how many people are affected worldwide, differences by sex and region, with sources.
C3 Glomerulopathy (C3G) is a rare kidney disorder characterized by abnormal deposits of a protein called C3 in the glomeruli, which are the tiny blood vessels in the kidneys responsible for filtering waste and excess fluid from the blood. C3G is a type of glomerulonephritis, a group of diseases that cause inflammation and damage to the glomeruli.
The prevalence of C3G is not well-established due to its rarity and the challenges in diagnosing the condition. However, studies suggest that it may account for approximately 1-3% of all glomerulonephritis cases. C3G can affect individuals of all ages, including children and adults, with a slight male predominance.
Although C3G is considered a rare disease, it is important to note that prevalence estimates may vary depending on the population studied and the diagnostic criteria used. Further research and awareness are needed to better understand the true prevalence of C3G and improve diagnosis and treatment options for affected individuals.
